@article{article, title = {{Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-δΌͺ Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},
publisher = {{Adis}},
url = {{http://eprints.whiterose.ac.uk/117002/ }},
year = {{2017}},
month = {{11}},
author = {{Bermejo I and Stevenson M and Archer R and Stevens JW and Goka E and Clowes M and Scott DL and Young A}},
doi = {{10.1007/s40273-017-0521-5}},
volume = {{35}},
journal = {{PharmacoEconomics}},
issue = {{11}},
pages = {{1141-1151}},
note = {{Accessed on 2025/07/03}}}